ELIC (ELIC) News
Follow ELIC (ELIC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Elicera Therapeutics receives agency approval to advance CARMA study
Elicera Therapeutics says it has received Medical Products Agency approval to advance its CARMA study.
REGULATION | Sep 17, 2026, 06:48 AM UTC
M
Elicera cleared to use highest ELC-301 dose before Phase IIa
Elicera Therapeutics AB received clearance to use the highest ELC-301 dose ahead of Phase IIa.
EQUITY | Sep 09, 2026, 06:53 AM UTC
M
Elicera receives first patent allowance for ELC-201
Elicera Therapeutics AB has received its first patent allowance for ELC-201.
EQUITY | Sep 01, 2026, 12:10 PM UTC
L
Elicera receives notice of allowance for U.S. patent application
Elicera has received a notice of allowance for its U.S. patent application.
EQUITY | Aug 28, 2026, 08:10 AM UTC
M
Elicera Therapeutics Q2 loss widens to SEK 6.3 million
Elicera Therapeutics reported a Q2 loss for the period of SEK 6.3 million.
EQUITY | Aug 28, 2026, 06:16 AM UTC
L
ELIC: Strong clinical results and new funding support continued pipeline progress in cell therapy
ELIC: Strong clinical results and new funding support continued pipeline progress in cell therapy
EQUITY | Aug 28, 2026, 06:06 AM UTC